TAAT® Subsidiary Beyond Alternatives Begins Producing Second Batch of Jayvees Edibles

Rhea-AI Summary

TAAT Global Alternatives Inc. (CSE: TAAT, OTCQX: TOBAF) has successfully launched its Jayvees brand of edibles, which sold out its initial batch within 14 days. Following this demand, the company’s subsidiary, Beyond Alternatives, has commenced production of a second batch, approximately 13% larger than the first. The edibles are now available in eleven U.S. states and Puerto Rico, with retailers reporting adult consumers purchasing an average of ten units per transaction. The Peanut Butter variety has emerged as a best seller, reflecting strong consumer interest and robust sales momentum.

Positive

• Jayvees edibles sold out within 14 days of launch.
• Second commercial batch of Jayvees is 13% larger than the first.
• Strong demand evidenced by retailers reporting average purchases of ten units at a time.
• Products are now available in eleven U.S. states and Puerto Rico.

Negative

• None.

After launching Jayvees in February 2023, the Company’s subsidiary Beyond Alternatives sold out its entire first commercial batch of Jayvees edibles in a 14-day period

LAS VEGAS and VANCOUVER, British Columbia, March 16, 2023 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that its subsidiary Beyond Alternatives LLC (“Beyond Alternatives”) has commenced production of the second commercial batch of edibles under the Jayvees brand. In a press release dated February 6, 2023, the Company announced that Beyond Alternatives would be launching Jayvees at the CHAMPS trade show being held in Las Vegas that same week. Jayvees was also featured in Beyond Alternatives’ exhibits at other B2B events such as Total Product Expo (TPE) and ASD Market Week, garnering overwhelmingly positive responses from attendees. Retailers of Jayvees edibles have reported that adult consumers often purchase several units of the product at a given time (approximately ten single-serving units per transaction on average). As of this writing, products under the Jayvees brand are sold in eleven U.S. states as well as in Puerto Rico.

Beyond Alternatives’ initial supply of Jayvees edibles was completely sold out approximately 14 days after becoming available for purchasing on a wholesale basis. The second batch, which will be approximately 13% larger than the first batch, is expected to be ready to ship later this month, with four wholesale pre-orders already confirmed.

Beyond Alternatives has started producing its second commercial batch of Jayvees edibles, which are pictured above as part of a display at a trade show exhibit.

Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.

TAAT® Chief Executive Officer Michael Saxon commented, “We are excited about the early-stage success of Jayvees, as we expand our footprint in the CPG space throughout the United States. Retailers seem to be further embracing edibles and other similar product offerings in 2023, and it is apparent that the Jayvees brand is resonating with adult consumers at the retail level, which is driving enough demand for us to begin manufacturing a second batch so promptly after the first.”

Pat Bell, President of TAAT® wholesale subsidiary ADCO Distributors, Inc. (“ADCO”), commented, “Although ADCO’s business is primarily in legacy convenience categories such as tobacco and confection, we have been scaling up our range of alternative products such as edibles. Our retail accounts have reported that adult consumers are purchasing approximately ten units of Jayvees at a time in-store, and we have had to be diligent about keeping up with demand to make sure they’re kept in stock. The Peanut Butter variety of Jayvees edibles is the best seller, and we are excited for the second batch to be ready to ship so that we can continue supplying Jayvees to our accounts.”

On behalf of the Board of Directors of the Company,

TAAT® GLOBAL ALTERNATIVES INC.

“Michael Saxon”

Michael Saxon, CEO and Director

For further information, please contact:

TAAT® Investor Relations
1-833-TAAT-USA (1-833-822-8872)
investor@taatglobal.com

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

About TAAT® Global Alternatives Inc.

TAAT® is a vertically integrated consumer product and distribution company, generating more than CAD $90 million in overall gross revenue annually. TAAT® is strategically expanding its product categories including tobacco and reduced-risk alternatives, hemp, kratom, and other emerging CPG segments. TAAT® has facilities to include a processing plant in Nevada as well as a distribution centre in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels.

For more information, please visit http://taatglobal.com.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to the following: Anticipated completion of the production of the second batch of Jayvees edibles, potential performance of Jayvees in the wholesale and retail markets. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; (iii) changes to the regulatory landscape applicable to the Company's business; and (iv) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.

The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.

This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Disclosures relating to investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the Company's profile on http://sedar.com.

FAQ

What is the recent sales performance of TAAT Global's Jayvees edibles?

TAAT Global's Jayvees edibles sold out their initial batch within 14 days of launch.

When will the second batch of Jayvees edibles be available?

The second batch of Jayvees edibles is expected to be ready for shipment later this month.

How many states are selling Jayvees edibles?

Jayvees edibles are currently available in eleven U.S. states and Puerto Rico.

What is the best selling variety of Jayvees edibles?

The Peanut Butter variety is reported as the best seller among Jayvees edibles.

What is the stock symbol for TAAT Global Alternatives Inc.?

The stock symbol for TAAT Global Alternatives Inc. is TOBAF.